No, The Market Is Not Getting Cheaper

The article argues that a 6% decline in market P/E over the past 3 months does not mean stocks are cheaper, emphasizing that the equity risk premium (ERP) is the better measure of valuation improvement. It is primarily a commentary on valuation and risk positioning rather than a market-moving event. No specific policy, earnings, or macro data release is cited.

Analysis

The market is being framed as “cheaper,” but the more important signal is that the valuation rerating is likely incomplete without a meaningful move in real rates or earnings breadth. A lower headline multiple can still be a bad buy if the denominator is deteriorating or if equity risk premium is not expanding enough to compensate for macro uncertainty; in that setup, index-level upside is capped while single-name dispersion rises. That favors active allocation over beta and argues for owning balance-sheet quality rather than simply reaching for cyclical beta.

For financials like NTRS, the implication is subtle: lower market multiples do not automatically help asset gatherers unless they translate into higher AUM, trading activity, or net interest margin support. If the market’s move is mainly multiple compression rather than a durable improvement in risk appetite, custody/wealth platforms can lag because clients remain cautious and cash allocations stay elevated. The second-order winner is typically firms with fee leverage to capital markets activity, not just passive exposure to broad equity levels.

The contrarian read is that investors may be underestimating how quickly sentiment can reverse if breadth improves even modestly. A small expansion in earnings revisions, not a huge index rally, is enough to make the “cheaper market” narrative self-fulfilling and force systematic re-risking over 4-8 weeks. The key risk is that this is a valuation trap: if real yields stay sticky and earnings estimates roll over, the apparent cheapness will disappear without prices having to fall much further.

Key Decisions for Investors

• Overweight quality factor baskets vs. broad beta for the next 4-8 weeks; favor cash-rich, low-leverage names that can outperform if multiples stay compressed.
• Neutral-to-slightly-underweight NTRS until you see evidence of higher market activity or improving inflows; use any rally tied to ‘cheap market’ narratives to fade exposure rather than add.
• Pair trade: long XLF high-fee activity beneficiaries / short low-beta asset gatherers if market volatility and turnover stay elevated for 1-2 months.
• Consider a tactical long SPY call spread only if breadth and earnings revisions improve simultaneously; otherwise the valuation compression is more likely a false signal.
• Set a trigger to add beta only if the equity risk premium rises meaningfully via lower real yields or upward earnings revisions, not just because the headline P/E fell.